These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38673493)
1. The Importance of Lung Ultrasound and IGFBP7 (Insulin-like Growth Factor Binding Protein 7) Assessment in Diagnosing Patients with Heart Failure. Szyszkowska A; Olesiewicz T; Płońska-Korabiewska I; Tarasiuk E; Olesiewicz B; Knapp M; Śledziewski R; Sobkowicz B; Lisowska A J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673493 [No Abstract] [Full Text] [Related]
2. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N; ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Kapłon-Cieślicka A; Benson L; Chioncel O; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Ruschitzka F; Hage C; Drożdż J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Maggioni AP; Lund LH; Eur J Heart Fail; 2022 Feb; 24(2):335-350. PubMed ID: 34962044 [TBL] [Abstract][Full Text] [Related]
4. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction. Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053 [TBL] [Abstract][Full Text] [Related]
5. Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure. Huusko J; Tuominen S; Studer R; Corda S; Proudfoot C; Lassenius M; Ukkonen H ESC Heart Fail; 2020 Oct; 7(5):2406-2417. PubMed ID: 32667143 [TBL] [Abstract][Full Text] [Related]
6. Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group? Webb J; Draper J; Fovargue L; Sieniewicz B; Gould J; Claridge S; Barton C; Smith S; Tondel K; Rajani R; Kapetanakis S; Rinaldi CA; McDonagh TA; Razavi R; Carr-White G Int J Cardiol Heart Vasc; 2018 Dec; 21():1-6. PubMed ID: 30202782 [TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting. Morvai-Illés B; Polestyuk-Németh N; Szabó IA; Monoki M; Gargani L; Picano E; Varga A; Ágoston G Front Cardiovasc Med; 2021; 8():758147. PubMed ID: 34926610 [No Abstract] [Full Text] [Related]
8. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial. Gandhi PU; Gaggin HK; Redfield MM; Chen HH; Stevens SR; Anstrom KJ; Semigran MJ; Liu P; Januzzi JL JACC Heart Fail; 2016 Nov; 4(11):860-869. PubMed ID: 27744089 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. Gandhi PU; Chow SL; Rector TS; Krum H; Gaggin HK; McMurray JJ; Zile MR; Komajda M; McKelvie RS; Carson PE; Januzzi JL; Anand IS J Card Fail; 2017 Jan; 23(1):20-28. PubMed ID: 27317843 [TBL] [Abstract][Full Text] [Related]
10. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study. Özlek B; Özlek E; Ağuş HZ; Tekinalp M; Kahraman S; Çil C; Çelik O; Başaran Ö; Doğan V; Kaya BC; Rencüzoğulları I; Ösken A; Bekar L; Çakır MO; Çelik Y; Mert KU; Sancar KM; Sevinç S; Mert GÖ; Biteker M Eur J Intern Med; 2019 Mar; 61():88-95. PubMed ID: 30446354 [TBL] [Abstract][Full Text] [Related]
11. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction. Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640 [TBL] [Abstract][Full Text] [Related]
12. Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Palazzuoli A; Ruocco G; Beltrami M; Nuti R; Cleland JG Clin Res Cardiol; 2018 Jul; 107(7):586-596. PubMed ID: 29532155 [TBL] [Abstract][Full Text] [Related]
13. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
14. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction. Fan L; Gu L; Yao Y; Ma G Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746 [TBL] [Abstract][Full Text] [Related]